Neural mechanisms underlying obesity and drug addiction

Physiology and Behavior

Volumn 91, Issue 5, 2007, Pages 499-505

  Trinko, Richard ^a   Sears, Robert M ^a   Guarnieri, Douglas J ^a   DiLeone, Ralph J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; Mechanisms; Obesity

Indexed keywords

DOPAMINE; LEPTIN;

ARTICLE; BEHAVIOR; BRAIN REGION; CENTRAL NERVOUS SYSTEM; DRUG DEPENDENCE; FOOD AVAILABILITY; FOOD INTAKE; HUMAN; LIMBIC CORTEX; METABOLIC REGULATION; MOTIVATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; REWARD; SUBTHALAMIC NUCLEUS;

EID: 34547828079     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2007.01.001     Document Type: Article

References (103)

1. Wise R.A. The role of reward pathways in the development of drug dependence. Pharmacol Ther 35 1-2 (1987) 227-263
2. Carr K.D. Augmentation of drug reward by chronic food restriction: behavioral evidence and underlying mechanisms. Physiol Behav 76 3 (2002) 353-364
3. Cannon C.M., Abdallah L., Tecott L.H., During M.J., and Palmiter R.D. Dysregulation of striatal dopamine signaling by amphetamine inhibits feeding by hungry mice. Neuron 44 3 (2004) 509-520
4. Small D.M., Zatorre R.J., Dagher A., Evans A.C., and Jones-Gotman M. Changes in brain activity related to eating chocolate: from pleasure to aversion. Brain 124 Pt 9 (2001) 1720-1733
5. Hyman S.E., Malenka R.C., and Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29 (2006) 565-598
6. Nestler E.J. Is there a common molecular pathway for addiction?. Nat Neurosci 8 11 (2005) 1445-1449
7. Wang G.J., Volkow N.D., Logan J., Pappas N.R., Wong C.T., Zhu W., et al. Brain dopamine and obesity. Lancet 357 9253 (2001) 354-357
8. Blendy J.A., Strasser A., Walters C.L., Perkins K.A., Patterson F., Berkowitz R., et al. Reduced nicotine reward in obesity: cross-comparison in human and mouse. Psychopharmacology (Berl) 180 2 (2005) 306-315
9. Anand B.K., and Brobeck J.R. Localization of a "feeding center" in the hypothalamus of the rat. Proc Soc Exp Biol Med 77 2 (1951) 323-324
10. Ingalls A.M., Dickie M.M., and Snell G.D. Obese, a new mutation in the house mouse. J Hered 41 12 (1950) 317-318
11. Coleman D.L. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 9 4 (1973) 294-298
12. Coleman D.L., and Hummel K.P. Effects of parabiosis of normal with genetically diabetic mice. Am J Physiol 217 5 (1969) 1298-1304
13. Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 83 7 (1995) 1263-1271
14. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 6505 (1994) 425-432
15. Elmquist J.K., Elias C.F., and Saper C.B. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22 2 (1999) 221-232
16. Ahima R.S., and Flier J.S. Annu Rev Physiol 62 (2000) 413-437
17. Cowley M.A., Smart J.L., Rubinstein M., Cerdan M.G., Diano S., Horvath T.L., et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411 6836 (2001) 480-484
18. Mercer J.G., Hoggard N., Williams L.M., Lawrence C.B., Hannah L.T., and Trayhurn P. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett 387 2-3 (1996) 113-116
19. Schwartz M.W., Seeley R.J., Campfield L.A., Burn P., and Baskin D.G. Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98 5 (1996) 1101-1106
20. Balthasar N., Dalgaard L.T., Lee C.E., Yu J., Funahashi H., Williams T., et al. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123 3 (2005) 493-505
21. Fulton S., Woodside B., and Shizgal P. Modulation of brain reward circuitry by leptin. Science 287 5450 (2000) 125-128
22. Shalev U., Yap J., and Shaham Y. Leptin attenuates acute food deprivation-induced relapse to heroin seeking. J Neurosci 21 4 (2001) RC129
23. Figlewicz D.P., Bennett J., Evans S.B., Kaiyala K., Sipols A.J., and Benoit S.C. Intraventricular insulin and leptin reverse place preference conditioned with high-fat diet in rats. Behav Neurosci 118 3 (2004) 479-487
24. Figlewicz D.P., Higgins M.S., Ng-Evans S.B., and Havel P.J. Leptin reverses sucrose-conditioned place preference in food-restricted rats. Physiol Behav 73 1-2 (2001) 229-234
25. Figlewicz D.P., and Woods S.C. Adiposity signals and brain reward mechanisms. Trends Pharmacol Sci 21 7 (2000) 235-236
26. Figlewicz D.P., Evans S.B., Murphy J., Hoen M., and Baskin D.G. Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat. Brain Res 964 1 (2003) 107-115
27. Hommel J.D., Trinko R., Sears R.M., Georgescu D., Liu Z.W., Gao X.B., et al. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 51 6 (2006) 801-810
28. Fulton S., Pissios P., Manchon R.P., Stiles L., Frank L., Pothos E.N., et al. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 51 6 (2006) 811-822
29. Bouret S.G., Draper S.J., and Simerly R.B. Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 304 5667 (2004) 108-110
30. Pinto S., Roseberry A.G., Liu H., Diano S., Shanabrough M., Cai X., et al. Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304 5667 (2004) 110-115
31. Krugel U., Schraft T., Kittner H., Kiess W., and Illes P. Basal and feeding-evoked dopamine release in the rat nucleus accumbens is depressed by leptin. Eur J Pharmacol 482 1-3 (2003) 185-187
32. Dhillon H., Zigman J.M., Ye C., Lee C.E., McGovern R.A., Tang V., et al. Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron 49 2 (2006) 191-203
33. Grill H.J., Schwartz M.W., Kaplan J.M., Foxhall J.S., Breininger J., and Baskin D.G. Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on food intake. Endocrinology 143 1 (2002) 239-246
34. Shanley L.J., Irving A.J., and Harvey J. Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity. J Neurosci 21 24 (2001) RC186
35. Figlewicz D.P., Szot P., Chavez M., Woods S.C., and Veith R.C. Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra. Brain Res 644 2 (1994) 331-334
36. Naleid A.M., Grace M.K., Cummings D.E., and Levine A.S. Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens. Peptides 26 11 (2005) 2274-2279
37. Wise R.A. Neurobiology of addiction. Curr Opin Neurobiol 6 2 (1996) 243-251
38. Wise R.A. Dopamine, learning and motivation. Nat Rev Neurosci 5 6 (2004) 483-494
39. Robinson T.E., and Berridge K.C. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95 Suppl 2 (2000) S91-S117
40. Kalivas P.W., and Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162 8 (2005) 1403-1413
41. Stratford T.R., Kelley A.E., and Simansky K.J. Blockade of GABAA receptors in the medial ventral pallidum elicits feeding in satiated rats. Brain Res 825 1-2 (1999) 199-203
42. Kelley A.E., and Swanson C.J. Feeding induced by blockade of AMPA and kainate receptors within the ventral striatum: a microinfusion mapping study. Behav Brain Res 89 1-2 (1997) 107-113
43. Zhang M., Gosnell B.A., and Kelley A.E. Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens. J Pharmacol Exp Ther 285 2 (1998) 908-914
44. Pecina S., and Berridge K.C. Hedonic hot spot in nucleus accumbens shell: where do mu-opioids cause increased hedonic impact of sweetness?. J Neurosci 25 50 (2005) 11777-11786
45. Zhang M., Balmadrid C., and Kelley A.E. Nucleus accumbens opioid, GABaergic, and dopaminergic modulation of palatable food motivation: contrasting effects revealed by a progressive ratio study in the rat. Behav Neurosci 117 2 (2003) 202-211
46. Taha S.A., and Fields H.L. Encoding of palatability and appetitive behaviors by distinct neuronal populations in the nucleus accumbens. J Neurosci 25 5 (2005) 1193-1202
47. Taha S.A., and Fields H.L. Inhibitions of nucleus accumbens neurons encode a gating signal for reward-directed behavior. J Neurosci 26 1 (2006) 217-222
48. Carelli R.M. Nucleus accumbens cell firing during goal-directed behaviors for cocaine vs. 'natural' reinforcement. Physiol Behav 76 3 (2002) 379-387
49. Carelli R.M., Ijames S.G., and Crumling A.J. Evidence that separate neural circuits in the nucleus accumbens encode cocaine versus "natural" (water and food) reward. J Neurosci 20 11 (2000) 4255-4266
50. Baldo B.A., Sadeghian K., Basso A.M., and Kelley A.E. Effects of selective dopamine D1 or D2 receptor blockade within nucleus accumbens subregions on ingestive behavior and associated motor activity. Behav Brain Res 137 1-2 (2002) 165-177
51. Aberman J.E., Ward S.J., and Salamone J.D. Effects of dopamine antagonists and accumbens dopamine depletions on time-constrained progressive-ratio performance. Pharmacol Biochem Behav 61 4 (1998) 341-348
52. Wyvell C.L., and Berridge K.C. Intra-accumbens amphetamine increases the conditioned incentive salience of sucrose reward: enhancement of reward "wanting" without enhanced "liking" or response reinforcement. J Neurosci 20 21 (2000) 8122-8130
53. Nicola S.M., Taha S.A., Kim S.W., and Fields H.L. Nucleus accumbens dopamine release is necessary and sufficient to promote the behavioral response to reward-predictive cues. Neuroscience 135 4 (2005) 1025-1033
54. Wise R.A. Role of brain dopamine in food reward and reinforcement. Philos Trans R Soc Lond B Biol Sci 361 1471 (2006) 1149-1158
55. Salamone J.D., Correa M., Mingote S.M., and Weber S.M. Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Curr Opin Pharmacol 5 1 (2005) 34-41
56. Zhou Q.Y., and Palmiter R.D. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83 7 (1995) 1197-1209
57. Cannon C.M., and Palmiter R.D. Reward without dopamine. J Neurosci 23 34 (2003) 10827-10831
58. Hnasko T.S., Sotak B.N., and Palmiter R.D. Morphine reward in dopamine-deficient mice. Nature 438 7069 (2005) 854-857
59. Szczypka M.S., Kwok K., Brot M.D., Marck B.T., Matsumoto A.M., Donahue B.A., et al. Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice. Neuron 30 3 (2001) 819-828
60. Hnasko T.S., Perez F.A., Scouras A.D., Stoll E.A., Gale S.D., Luquet S., et al. Cre recombinase-mediated restoration of nigrostriatal dopamine in dopamine-deficient mice reverses hypophagia and bradykinesia. Proc Natl Acad Sci U S A 103 23 (2006) 8858-8863
61. Stratford T.R., and Kelley A.E. Evidence of a functional relationship between the nucleus accumbens shell and lateral hypothalamus subserving the control of feeding behavior. J Neurosci 19 24 (1999) 11040-11048
62. Heimer L., Zahm D.S., Churchill L., Kalivas P.W., and Wohltmann C. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience 41 1 (1991) 89-125
63. Broberger C., De Lecea L., Sutcliffe J.G., and Hokfelt T. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol 402 4 (1998) 460-474
64. Baldo B.A., Gual-Bonilla L., Sijapati K., Daniel R.A., Landry C.F., and Kelley A.E. Activation of a subpopulation of orexin/hypocretin-containing hypothalamic neurons by GABAA receptor-mediated inhibition of the nucleus accumbens shell, but not by exposure to a novel environment. Eur J Neurosci 19 2 (2004) 376-386
65. Zheng H., Corkern M., Stoyanova I., Patterson L.M., Tian R., and Berthoud H.R. Peptides that regulate food intake: appetite-inducing accumbens manipulation activates hypothalamic orexin neurons and inhibits POMC neurons. Am J Physiol Regul Integr Comp Physiol 284 6 (2003) R1436-R1444
66. Kelley A.E., Baldo B.A., Pratt W.E., and Will M.J. Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward. Physiol Behav 86 5 (2005) 773-795
67. van der Kooy D., Mucha R.F., O'Shaughnessy M., and Bucenieks P. Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference. Brain Res 243 1 (1982) 107-117
68. Corrigall W.A. Heroin self-administration: effects of antagonist treatment in lateral hypothalamus. Pharmacol Biochem Behav 27 4 (1987) 693-700
69. DiLeone R.J., Georgescu D., and Nestler E.J. Lateral hypothalamic neuropeptides in reward and drug addiction. Life Sci 73 6 (2003) 759-768
70. Georgescu D., Zachariou V., Barrot M., Mieda M., Willie J.T., Eisch A.J., et al. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 23 8 (2003) 3106-3111
71. Harris G.C., Wimmer M., and Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437 7058 (2005) 556-559
72. Boutrel B., Kenny P.J., Specio S.E., Martin-Fardon R., Markou A., Koob G.F., et al. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A 102 52 (2005) 19168-19173
73. Borgland S.L., Taha S.A., Sarti F., Fields H.L., and Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49 4 (2006) 589-601
74. Fadel J., and Deutch A.Y. Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 111 2 (2002) 379-387
75. Nakamura T., Uramura K., Nambu T., Yada T., Goto K., Yanagisawa M., et al. Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res 873 1 (2000) 181-187
76. Narita M., Nagumo Y., Hashimoto S., Narita M., Khotib J., Miyatake M., et al. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 26 2 (2006) 398-405
77. Qu D., Ludwig D.S., Gammeltoft S., Piper M., Pelleymounter M.A., Cullen M.J., et al. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380 6571 (1996) 243-247
78. Shimada M., Tritos N.A., Lowell B.B., Flier J.S., and Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396 6712 (1998) 670-674
79. Ludwig D.S., Tritos N.A., Mastaitis J.W., Kulkarni R., Kokkotou E., Elmquist J., et al. Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J Clin Invest 107 3 (2001) 379-386
80. Segal-Lieberman G., Bradley R.L., Kokkotou E., Carlson M., Trombly D.J., Wang X., et al. Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype. Proc Natl Acad Sci U S A 100 17 (2003) 10085-10090
81. Bachner D., Kreienkamp H., Weise C., Buck F., and Richter D. Identification of melanin concentrating hormone (MCH) as the natural ligand for the orphan somatostatin-like receptor 1 (SLC-1). FEBS Lett 457 3 (1999) 522-524
82. Chambers J., Ames R.S., Bergsma D., Muir A., Fitzgerald L.R., Hervieu G., et al. Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature 400 6741 (1999) 261-265
83. Lembo P.M., Grazzini E., Cao J., Hubatsch D.A., Pelletier M., Hoffert C., et al. The receptor for the orexigenic peptide melanin-concentrating hormone is a G-protein-coupled receptor. Nat Cell Biol 1 5 (1999) 267-271
84. Saito Y., Nothacker H.P., Wang Z., Lin S.H., Leslie F., and Civelli O. Molecular characterization of the melanin-concentrating-hormone receptor. Nature 400 6741 (1999) 265-269
85. Chen Y., Hu C., Hsu C.K., Zhang Q., Bi C., Asnicar M., et al. Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. Endocrinology 143 7 (2002) 2469-2477
86. Marsh D.J., Weingarth D.T., Novi D.E., Chen H.Y., Trumbauer M.E., Chen A.S., et al. Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci U S A 99 5 (2002) 3240-3245
87. Borowsky B., Durkin M.M., Ogozalek K., Marzabadi M.R., DeLeon J., Lagu B., et al. Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat Med 8 8 (2002) 825-830
88. Takekawa S., Asami A., Ishihara Y., Terauchi J., Kato K., Shimomura Y., et al. T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist. Eur J Pharmacol 438 3 (2002) 129-135
89. Georgescu D., Sears R.M., Hommel J.D., Barrot M., Bolanos C.A., Marsh D.J., et al. The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. J Neurosci 25 11 (2005) 2933-2940
90. Roche K.W., O'Brien R.J., Mammen A.L., Bernhardt J., and Huganir R.L. Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron 16 6 (1996) 1179-1188
91. Gao X.B., and van Den Pol A.N. Melanin concentrating hormone depresses synaptic activity of glutamate and GABA neurons from rat lateral hypothalamus. J Physiol 533 Pt 1 (2001) 237-252
92. Smith D.G., Tzavarra E.T., Shaw J., Luecke S., Wade M., Davis R., et al. Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice. J Neurosci 25 4 (2005) 914-922
93. Colantuoni C., Rada P., McCarthy J., Patten C., Avena N.M., Chadeayne A., et al. Evidence that intermittent, excessive sugar intake causes endogenous opioid dependence. Obes Res 10 6 (2002) 478-488
94. Colantuoni C., Schwenker J., McCarthy J., Rada P., Ladenheim B., Cadet J.L., et al. Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain. NeuroReport 12 16 (2001) 3549-3552
95. Rada P., Avena N.M., and Hoebel B.G. Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell. Neuroscience 134 3 (2005) 737-744
96. Le Merrer J., and Stephens D.N. Food-induced behavioral sensitization, its cross-sensitization to cocaine and morphine, pharmacological blockade, and effect on food intake. J Neurosci 26 27 (2006) 7163-7171
97. Ayyad C., and Andersen T. Long-term efficacy of dietary treatment of obesity: a systematic review of studies published between 1931 and 1999. Obes Rev 1 2 (2000) 113-119
98. Ghitza U.E., Gray S.M., Epstein D.H., Rice K.C., and Shaham Y. The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF(1) receptors. Neuropsychopharmacology 31 10 (2005) 2188-2196
99. Petrovich G.D., Setlow B., Holland P.C., and Gallagher M. Amygdalo-hypothalamic circuit allows learned cues to override satiety and promote eating. J Neurosci 22 19 (2002) 8748-8753
100. Holland P.C., and Petrovich G.D. A neural systems analysis of the potentiation of feeding by conditioned stimuli. Physiol Behav 86 5 (2005) 747-761
101. Petrovich G.D., Holland P.C., and Gallagher M. Amygdalar and prefrontal pathways to the lateral hypothalamus are activated by a learned cue that stimulates eating. J Neurosci 25 36 (2005) 8295-8302
102. Baunez C., Dias C., Cador M., and Amalric M. The subthalamic nucleus exerts opposite control on cocaine and 'natural' rewards. Nat Neurosci 8 4 (2005) 484-489
103. Sakai R.R., Fine W.B., Epstein A.N., and Frankmann S.P. Salt appetite is enhanced by one prior episode of sodium depletion in the rat. Behav Neurosci 101 5 (1987) 724-731